MILWAUKEE, Feb. 21, 2018 /PRNewswire/ -- V3 Health Strategy, a Wisconsin based solutions
V3 Health Strategy – Private Placement ICO Model, is a novel new addition to the portfolio of tiered consulting solutions. V3 is powered by a multi-faceted team of seasoned healthcare professionals, providing comprehensive tertiary level advisory services, with access to a vast domain of custom on-demand resources, located around the world. According to Alan Gilbert, MPA and Chief Growth Officer, "After decades in the healthcare domain, I have not witnessed a more timely hybrid solution in the market. The application of a blockchain infrastructure can have a significant positive impact in the clinical, financial, and administrative functions in healthcare. Never before has a revolutionary change come to healthcare that has the real opportunity to bend the cost curve and truly improve outcomes, reduce cost, and make healthcare more efficient. The ability to now utilize a 'cyber-token' model to incentivize positive outcomes for patients, providers, and other ecosystem members, is exciting. This unique customizable advisory services portfolio is available in snapshot scope (bronze), augmented growth (silver) and comprehensive (gold) packages, dependent on the needs of the healthcare customer."
About V3 Health Strategy
Based in Milwaukee, Wisconsin, V3 Health Strategy's unique portfolio of Next Generation Blockchain Consulting services, brings forth superiority over conventional services. V3's solutions include advanced healthcare information technology, deep learning, artificial intelligence, genomics, blockchain and initial coin offerings (ICO).
CONTACT: Dr Paul Markhampaul.firstname.lastname@example.org +1.414.687.0272
View original content:http://www.prnewswire.com/news-releases/v3-health-strategy-launches-its-unique-blockchain-private-placement-ico-solution-300601667.html
SOURCE V3 Health Strategy
Subscribe to our Free Newsletters!
Alström syndrome, a rare genetic disorder due to ALMS1 mutations, occurs in the first year of ...
Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...
Encephalocele is a birth defect where a sac like protrusion of brain and covering membranes occurs ...View All